Table I.
Correlation between podoplanin expression and patient characteristics.
| Low podoplanin expression (n=27) | High podoplanin expression (n=13) | P-value | |
|---|---|---|---|
| Age at diagnosis | |||
| <60 years | 18 | 10 | 0.716 |
| ≥60 years | 9 | 3 | |
| Gender | |||
| Female | 17 | 5 | 0.314 |
| Male | 10 | 8 | |
| T classification | |||
| I or II | 15 | 5 | 0.501 |
| III or IV | 12 | 8 | |
| Regional metastasis | |||
| With | 3 | 0 | 0.538 |
| Without | 24 | 13 | |
| Distant metastasis | |||
| With | 7 | 9 | 0.015 |
| Without | 20 | 4 | |
| Recurrence | |||
| With | 7 | 4 | 1.000 |
| Without | 20 | 9 | |
| Histological grading | |||
| I | 11 | 5 | 0.644 |
| II | 13 | 5 | |
| III | 3 | 3 | |
| SACC tumor location (gland) | |||
| Parotid | 4 | 0 | 0.199 |
| Submaxillary | 4 | 1 | |
| Sublingual | 5 | 6 | |
| Small | 14 | 6 |
SACC, salivary gland adenoid cystic carcinoma.